Treatment of isolated systolic hypertension in elderly people*

Outcomes at mean 3.8 yearsOdds ratio reduction (95% CI)NNT (CI)
*Abbreviations defined in glossary. 1 trial was not a randomised controlled trial; re-analysis without this trial did not alter outcomes significantly.
All cause mortality13% (2 to 22)59 (55 to 64)
Cardiovascular mortality18% (4 to 29)79 (72 to 89)
All cardiovascular events26% (17 to 34)26 (25 to 27)
All stroke events30% (18 to 41)48 (45 to 51)
All coronary events23% (10 to 34)64 (59 to 70)